UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 


 

Date of Report:  May 3, 2013

(Date of earliest event reported)

 


 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

Nevada

 

1-7293

 

95-2557091

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification Number)

 

1445 Ross Avenue, Suite 1400

Dallas, Texas  75202

(Address of principal executive offices, including zip code)

 

(469) 893-2200

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07                   Submission of Matters to a Vote of Security Holders.

 

(a)   The 2013 annual meeting of shareholders of Tenet Healthcare Corporation was held on May 3, 2013.

 

(b)   The shareholders (1) elected all of the board’s nominees for director, (2) approved an advisory resolution on the compensation paid to the company’s named executive officers, and (3) ratified the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2013.

 

The final results of voting on each of the matters submitted to a vote are as follows:

 

1.  Election of directors:

 

 

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER 
NON-
VOTES

 

John Ellis “Jeb” Bush

 

88,460,094

 

235,098

 

817,962

 

7,685,786

 

Trevor Fetter

 

88,461,021

 

230,577

 

821,556

 

7,685,786

 

Brenda J. Gaines

 

82,401,540

 

6,281,877

 

829,737

 

7,685,786

 

Karen M. Garrison

 

88,462,260

 

219,999

 

830,895

 

7,685,786

 

Edward A. Kangas

 

87,982,318

 

702,656

 

828,180

 

7,685,786

 

J. Robert Kerrey

 

88,109,726

 

573,911

 

829,517

 

7,685,786

 

Richard R. Pettingill

 

88,145,245

 

539,131

 

828,778

 

7,685,786

 

Ronald A. Rittenmeyer

 

88,478,903

 

204,830

 

829,421

 

7,685,786

 

James A. Unruh

 

86,460,753

 

221,336

 

831,065

 

7,685,786

 

 

2.  Approval of an advisory resolution on the compensation paid to the company’s named executive officers:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-
VOTES

 

86,645,238

 

1,174,722

 

1,693,194

 

7,685,786

 

 

2



 

3.  Ratification of the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2013:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-
VOTES

 

95,656,909

 

702,451

 

839,580

 

 

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TENET HEALTHCARE CORPORATION

 

 

 

 

 

By:

/s/ Paul A. Castanon

 

 

Paul A. Castanon

 

 

Vice President, Deputy General Counsel

 

 

and Corporate Secretary

 

 

 

Date: May 6, 2013

 

 

4